Completed NA INTERVENTIONAL 2-arm NCT04486794

Restylane® for the Treatment of Tear Trough Deformity

A Clinical Evaluation of the Efficacy and Safety of Hyaluronic Acid (Restylane®) for the Treatment of Tear Trough Deformity

Sponsor: Erevna Innovations Inc.

Conditions Tear Trough Eyelid Deformity

Interventions Restylane®

Updated 6 times since 2020 Last updated: Feb 7, 2021 Started: Jul 7, 2019 Primary completion: Dec 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Tear Trough Eyelid Deformity and is currently completed. Erevna Innovations Inc. leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2021 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed · Phase: PHASE4 → NA
Jan 2021 — Mar 2021 [monthly]

Active Not Recruiting PHASE4
Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Aug 2020 — Oct 2020 [monthly]

Recruiting PHASE4

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erevna Innovations Inc.

Data source: Erevna Innovations Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada